107 related articles for article (PubMed ID: 32565127)
1. Comparison of Overall Survival Between De Novo and Secondary Acute Lymphoblastic Leukemia Patients of Different Ages.
Zhong J; Yu X; Zhang X
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e622-e627. PubMed ID: 32565127
[TBL] [Abstract][Full Text] [Related]
2. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
[TBL] [Abstract][Full Text] [Related]
3. Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.
Swaika A; Frank RD; Yang D; Finn LE; Jiang L; Advani P; Chanan-Khan AA; Ailawadhi S; Foran JM
Cancer Med; 2018 Feb; 7(2):499-507. PubMed ID: 29282894
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patients.
Petit B; Mele L; Rack K; Camera A; Vekemans MC; Bassan R; Pulsoni A; Delannoy A; Pagano L
Leuk Lymphoma; 2002 Aug; 43(8):1599-604. PubMed ID: 12400602
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
[TBL] [Abstract][Full Text] [Related]
6. Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database.
Giri S; Pathak R; Martin MG; Bhatt VR
Leuk Lymphoma; 2016 Feb; 57(2):385-391. PubMed ID: 26084205
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to
Aldoss I; Stiller T; Tsai NC; Song JY; Cao T; Bandara NA; Salhotra A; Khaled S; Aribi A; Al Malki MM; Mei M; Ali H; Spielberger R; O'Donnell M; Snyder D; Slavin T; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
Haematologica; 2018 Oct; 103(10):1662-1668. PubMed ID: 29903756
[TBL] [Abstract][Full Text] [Related]
8. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
[TBL] [Abstract][Full Text] [Related]
9. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
Atsuta Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kasai M; Fukuda T; Azuma H; Takanashi M; Okamoto S; Tsuchida M; Kawa K; Morishima Y; Kodera Y; Kato S;
Blood; 2009 Feb; 113(8):1631-8. PubMed ID: 19104080
[TBL] [Abstract][Full Text] [Related]
10. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
[TBL] [Abstract][Full Text] [Related]
11. Area deprivation is associated with poorer overall survival in children with acute lymphoblastic leukemia.
Schraw JM; Peckham-Gregory EC; Rabin KR; Scheurer ME; Lupo PJ; Oluyomi A
Pediatr Blood Cancer; 2020 Sep; 67(9):e28525. PubMed ID: 32573920
[TBL] [Abstract][Full Text] [Related]
12. Can Less Intensive Chemotherapy and an Autotransplant Cure Adult T-Cell Acute Lymphoblastic Leukemia?
Parovichnikova E; Troitskaya V; Sokolov A; Gavrilina O; Akhmerzaeva Z; Kuzmina L; Kliasova G; Chabaeva J; Kulikov S; Bondarenko S; Baranova O; Samoilova O; Kaplanov K; Minaeva N; Savchenko V;
Acta Haematol; 2020; 143(2):131-139. PubMed ID: 31597157
[TBL] [Abstract][Full Text] [Related]
13. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
Ruggeri A; Labopin M; Sanz G; Piemontese S; Arcese W; Bacigalupo A; Blaise D; Bosi A; Huang H; Karakasis D; Koc Y; Michallet M; Picardi A; Sanz J; Santarone S; Sengelov H; Sierra J; Vincent L; Volt F; Nagler A; Gluckman E; Ciceri F; Rocha V; Mohty M; ;
Leukemia; 2015 Sep; 29(9):1891-900. PubMed ID: 25882700
[TBL] [Abstract][Full Text] [Related]
14. Survival disparities by age and country of diagnosis for patients with acute leukemia.
Redaniel MT; Pulte D; Jeffreys M
Leuk Lymphoma; 2015; 56(10):2787-92. PubMed ID: 25669926
[TBL] [Abstract][Full Text] [Related]
15. Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.
Schmaelter AK; Labopin M; Socié G; Itälä-Remes M; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Ganser A; Beelen D; Labussière-Wallet H; Passweg J; Savani BN; Schmid C; Nagler A; Mohty M
Blood Cancer J; 2020 Mar; 10(3):26. PubMed ID: 32127519
[TBL] [Abstract][Full Text] [Related]
16. Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
Le QH; Thomas X; Ecochard R; Iwaz J; Lhéritier V; Michallet M; Fiere D
Cancer; 2007 May; 109(10):2058-67. PubMed ID: 17407135
[TBL] [Abstract][Full Text] [Related]
17. Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT.
Piemontese S; Boumendil A; Labopin M; Schmid C; Ciceri F; Arcese W; Koc Y; Gulbas Z; Tischer J; Bruno B; Wu D; Blaise D; Beelen D; Irrera G; Ruggeri A; Houhou M; Mohty M; Nagler A;
J Hematol Oncol; 2019 Jul; 12(1):68. PubMed ID: 31272508
[TBL] [Abstract][Full Text] [Related]
18. Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemia.
Pole JD; Darmawikarta D; Alibhai SM; Brandwein JM; Sung L
Leuk Res; 2013 Oct; 37(10):1258-64. PubMed ID: 23867057
[TBL] [Abstract][Full Text] [Related]
19. Understanding disparities in leukemia: a national study.
Patel MI; Ma Y; Mitchell BS; Rhoads KF
Cancer Causes Control; 2012 Nov; 23(11):1831-7. PubMed ID: 22971999
[TBL] [Abstract][Full Text] [Related]
20. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
Kantarjian HM; DeAngelo DJ; Stelljes M; Martinelli G; Liedtke M; Stock W; Gökbuget N; O'Brien S; Wang K; Wang T; Paccagnella ML; Sleight B; Vandendries E; Advani AS
N Engl J Med; 2016 Aug; 375(8):740-53. PubMed ID: 27292104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
